Display options
Share it on

Curr Pathobiol Rep. 2015 Jun;3(2):155-161. doi: 10.1007/s40139-015-0081-3.

Modeling Disorders of Blood Coagulation in the Zebrafish.

Current pathobiology reports

Colin A Kretz, Angela C Weyand, Jordan A Shavit

Affiliations

  1. Life Sciences Institute, University of Michigan, Ann Arbor, MI, USA.
  2. Division of Pediatric Hematology/Oncology, Department of Pediatrics and Communicable Diseases, University of Michigan, Ann Arbor, MI, USA.

PMID: 26146595 PMCID: PMC4486494 DOI: 10.1007/s40139-015-0081-3

Abstract

Hemostasis, the process of blood clot formation and resolution in response to vascular injury, and thrombosis, the dysregulation of hemostasis leading to pathological clot formation, are widely studied. However, the genetic variability in hemostatic and thrombotic disorders is incompletely understood, suggesting that novel mediators have yet to be uncovered. The zebrafish is developing into a powerful in vivo model to study hemostasis, and its features as a model organism are well suited to (a) develop high-throughput screens to identify novel mediators of hemostasis and thrombosis, (b) validate candidate genes identified in human populations, and (c) characterize the structure/function relationship of gene products. In this review, we discuss conservation of the zebrafish hemostatic system, highlight areas for future study, and outline the utility of this model to study blood coagulation and its dysregulation.

Keywords: Blood coagulation; Hemostasis; High-throughput screening; Thrombocytes; Zebrafish (Danio rerio)

References

  1. Blood. 2013 Oct 24;122(17):3074-81 - PubMed
  2. Blood. 2014 Jul 3;124(1):142-50 - PubMed
  3. Exp Hematol. 2009 Aug;37(8):901-8 - PubMed
  4. Blood Cells Mol Dis. 2014 Jan;52(1):76-81 - PubMed
  5. J Exp Biol. 1998 Feb;201(Pt 4):599-608 - PubMed
  6. Science. 1964 Sep 18;145(3638):1310-2 - PubMed
  7. Cell. 1999 Jan 8;96(1):111-20 - PubMed
  8. Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7603-7 - PubMed
  9. Blood Cells Mol Dis. 2004 Jan-Feb;32(1):191-8 - PubMed
  10. Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2079-93 - PubMed
  11. Nat Genet. 2012 Feb 26;44(4):435-9, S1-2 - PubMed
  12. J Clin Invest. 1998 Jan 15;101(2):321-6 - PubMed
  13. Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7597-602 - PubMed
  14. Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8768-73 - PubMed
  15. Nat Biotechnol. 2011 Aug 05;29(8):697-8 - PubMed
  16. Blood. 2014 May 1;123(18):2873-81 - PubMed
  17. Blood. 2014 Apr 3;123(14):2278-81 - PubMed
  18. Blood. 2009 May 7;113(19):4754-62 - PubMed
  19. Genome Dyn. 2006;2:183-97 - PubMed
  20. J Thromb Haemost. 2005 Aug;3(8):1561-8 - PubMed
  21. J Thromb Haemost. 2010 Jun;8(6):1159-69 - PubMed
  22. Development. 1996 Dec;123:303-9 - PubMed
  23. Nat Genet. 2011 Jul 17;43(8):735-7 - PubMed
  24. Thromb Haemost. 2012 Jan;107(1):158-66 - PubMed
  25. Semin Thromb Hemost. 2009 Jun;35(4):356-66 - PubMed
  26. Blood Cells Mol Dis. 2010 Dec 15;45(4):326-33 - PubMed
  27. Blood. 2014 Aug 14;124(7):1020-8 - PubMed
  28. Nature. 1964 May 2;202:498-9 - PubMed
  29. J Clin Invest. 2000 Oct;106(7):873-8 - PubMed
  30. Adv Hematol. 2012;2012:214209 - PubMed
  31. Blood. 2009 Dec 17;114(26):5368-74 - PubMed
  32. Biochem Biophys Res Commun. 2013 Nov 1;440(4):714-24 - PubMed
  33. Dev Cell. 2015 Jan 12;32(1):97-108 - PubMed
  34. J Clin Invest. 2012 Jul;122(7):2337-43 - PubMed
  35. Nature. 2011 Nov 30;480(7376):201-8 - PubMed
  36. Blood. 2014 Jul 10;124(2):220-8 - PubMed
  37. ACS Chem Biol. 2010 Feb 19;5(2):159-61 - PubMed
  38. ACS Nano. 2012 Nov 27;6(11):9900-10 - PubMed
  39. Cell Stem Cell. 2011 Apr 8;8(4):445-58 - PubMed
  40. Blood Cells Mol Dis. 2002 Nov-Dec;29(3):286-95 - PubMed
  41. Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7527-32 - PubMed
  42. J Thromb Haemost. 2003 Jul;1(7):1487-94 - PubMed
  43. Nat Biotechnol. 2013 Mar;31(3):227-9 - PubMed
  44. Biochim Biophys Acta. 1994 Dec 8;1215(3):291-9 - PubMed
  45. Blood Cells Mol Dis. 2002 Jul-Aug;29(1):57-68 - PubMed
  46. PLoS One. 2013 Sep 30;8(9):e74682 - PubMed
  47. Nature. 2000 Feb 17;403(6771):776-81 - PubMed
  48. Blood. 2008 Feb 1;111(3):1266-73 - PubMed
  49. J Biol Chem. 2011 Jul 22;286(29):25763-9 - PubMed
  50. Nat Biotechnol. 2008 Jun;26(6):695-701 - PubMed
  51. J Clin Invest. 2001 Aug;108(4):619-23 - PubMed
  52. Blood. 2008 Apr 1;111(7):3331-42 - PubMed
  53. Adv Hematol. 2012;2012:857058 - PubMed
  54. Nature. 2013 Apr 25;496(7446):498-503 - PubMed
  55. Br J Haematol. 1999 Dec;107(4):731-8 - PubMed
  56. J Thromb Haemost. 2012 May;10(5):859-66 - PubMed
  57. Genome Res. 2006 Apr;16(4):491-7 - PubMed
  58. Genes Dev. 1995 Aug 15;9(16):2020-33 - PubMed
  59. Chest. 2012 Feb;141(2 Suppl):e120S-51S - PubMed
  60. Thromb Haemost. 2003 Mar;89(3):420-8 - PubMed
  61. Development. 1996 Dec;123:311-9 - PubMed
  62. Blood. 2005 Dec 1;106(12):3803-10 - PubMed
  63. J Thromb Haemost. 2005 Dec;3(12):2730-7 - PubMed
  64. Development. 1996 Dec;123:1-36 - PubMed
  65. PLoS One. 2009;4(2):e4348 - PubMed
  66. Nature. 2007 Jun 21;447(7147):1007-11 - PubMed
  67. Circulation. 2002 May 7;105(18):2139-42 - PubMed
  68. J Thromb Haemost. 2007 Feb;5(2):329-35 - PubMed
  69. Blood Cells Mol Dis. 2006 Mar-Apr;36(2):131-4 - PubMed
  70. Zebrafish. 2009 Mar;6(1):69-77 - PubMed
  71. Blood. 2006 Nov 1;108(9):3061-7 - PubMed
  72. Blood. 2010 Nov 25;116(22):4646-56 - PubMed

Publication Types

Grant support